Y020-3093 Screening compound: 4-chloro-N-{5-[3-(dimethylamino)propyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}benzene-1-sulfonamide

Y020-3093 Screening compound: 4-chloro-N-{5-[3-(dimethylamino)propyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}benzene-1-sulfonamide
Y020-3093 Screening compound: 4-chloro-N-{5-[3-(dimethylamino)propyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-3093
4-chloro-N-{5-[3-(dimethylamino)propyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-3093

Molecular Formula

C14H22ClN5O2S (C14 H22 ClN5 O2 S)

Compound Name

4-chloro-N-{5-[3-(dimethylamino)propyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}benzene-1-sulfonamide

IUPAC name

4-chloro-N-{5-[3-(dimethylamino)propyl]-1456-tetrahydro-135-triazin-2-yl}benzene-1-sulfonamide

SMILES

CN(C)CCCN1CN=C(NS(c(cc2)ccc2Cl)(=O)=O)NC1

InChI

InChI=1S/C14H22ClN5O2S/c1-19(2)8-3-9-20-10-16-14(17-11-20)18-23(21,22)13-6-4-12(15)5-7-13/h4-7H,3,8-11H2,1-2H3,(H2,16,17,18)

InChI Key

XLYXXPVJYGFDGS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD13372314

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

359.88

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.445

Distribution Coefficient, logD

1.445

Water Solubility, LogSw

-2.81

Polar Surface Area

68.897

Acid Dissociation Constant (pKa)

7.38

Base Dissociation Constant (pKb)

9.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

50.00

Y020-3093 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y020-3093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-3093?
Check Price and Availability of Y020-3093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-3093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-3093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-3093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-3093 available by request